Finally, if you have concerns about medication costs, side effects, or treatment goals , raise these with your GP
Its often used in clinical settings for targeted fat loss
With economic uncertainty looming large, financial concerns are the biggest consideration for the majority of consumerswhich is why households are choosing to eat at home more often and increasingly opting for private labels at the grocery store
Key Industry Highlights: Dominant Segment : Ozempic leads the GLP-1 receptor agonist market in 2025 , with a 32.1% share , driven by its strong clinical efficacy in HbA1c reduction, proven cardiovascular benefits, and superior weight-loss outcomes
Breaking it down: What science says It depends on the goal whether you are choosing diabetes management or chronic weight loss